Furthermore, it has been reported that, apart from the standard CD44s isoform, some other CD44 isoforms increase the invasive capability of the MCF7 breast cancer cell line through different pathways, such as CD44st through the Ras/MARK signalling pathway [128,129]. Here, CD44 is linked to breast carcinoma.